Former Showa Denko Advisor Dr. Yorikatsu Hohokabe Joins Oblon, Spivak
For Immediate Release
Alexandria, Va. – Oblon, Spivak, McClelland, Maier & Neustadt, P.C. is pleased to announce that Dr. Yorikatsu Hohokabe has joined the firm as a Senior Technical Advisor in the firm’s Chemical and Biotechnology Practice Group. Dr. Hohokabe is a former Senior Advisor to the Showa Denko K.K. Corporation, a diversified group of manufacturing companies, active in personal care products, environmental goods, automotive parts and electronics.
In 1971, Dr. Hohokabe began his notable career in the central research laboratory of Showa Denko K.K. working on new product development. For nearly 40 years, Dr. Hohokabe held many positions of increasing responsibility at the company including Corporate R&D Manager, New Product Development, and Councilor, Chief Technologist, Corporate Officer and General Manager of the Intellectual Property Department. During his work for Showa Denko, he completed a Postdoctoral appointment at the University of Maryland.
Among other appointments and memberships, Dr. Hohokabe currently is a member of the Committee on Intellectual Property, and a member of the Sub-Committee on Policy Planning of the Committee on Intellectual Property, of the Nippon Keidanren, Co-Chair of the Chemicals, Energy & Environmental Committee of LES International, a Director and Board member of the Licensing Executives Society of Japan, a Director of the Industrial Property Cooperation Center and a Councilor of the Japan Patent Information Organization.
Dr. Hohokabe holds a Doctor of Engineering and a Masters of Engineering, both in Chemical Engineering, from the Tokyo Institute of Technology.
Assisting clients for 40 years, Oblon, Spivak, McClelland, Maier & Neustadt, P.C., in Alexandria, Va., is one of the largest intellectual property specialty firms in the United States. The firm provides a full range of intellectual property services, including litigation matters in all courts. The firm also continues to have a significant trademark, copyright and patent interference practice.